ALBAN BESSEDE, PHDChief Executive OfficerHolding a specific expertise in cancer immunotherapy models, Alban (also CEO of ImmuSmol) actively contributes to the discussion of clients' studies.
IMANE NAFIA, PhDChief Scientific OfficerBenefiting from a broad scientific background, Imane is taking care of the definition, design and reporting of clients' studies.
LOÏC CERF, MSCChief Operating OfficerHaving managed preclinical studies for over 10 years, Loïc is in charge of planning supervision, operatonial coordination and logistics of studies.